| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Chief Executive Officer | Director
3 companies
Riggs Rory B serves as a Director, 10% Owner at CBUS and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 3 buys and 49 sells. Those positions are worth an estimated $22.4M at current prices.
Historically, Riggs Rory B's trades have earned a middling insider score of 67/100 across 29 rated trades. Over a 12-month horizon, 65.5% of those trades were profitable, with an average 12-month return of +6.2%.
The biggest single holding is CBUS (~$22.4M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 518,107 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | RPRX Royalty Pharma Plc | - | Sell10b5-1 | 470,000 | $28.13 | $13,222,861.61 | -95.9% | +3.6% | -7.1% | |
| Dec 12, 2023 | CBUS Cibus, Inc. | Chief Executive Officer | Buy | 517,107 | $10.58 | $5,470,992.06 | +46.8% | +72.3% | -60.7% | |
| Jun 1, 2023 | CBUS Cibus, Inc. | Chief Executive Officer | Buy | 1,000 | $31.50 | $31,500.00 | - | -41.7% | -44.5% | |
| May 22, 2023 | RPRX Royalty Pharma Plc | Director | Sell | 1,750,000 | $32.82 | $57,435,000.00 | -99.6% | -11.2% | -18.6% | |
| Mar 30, 2023 | RPRX Royalty Pharma Plc | Director | Sell | 139,950 | $36.31 | $5,081,110.88 | -8.8% | -18.5% | -16.3% | |
| Dec 9, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 19,990 | $42.07 | $840,939.32 | -12.8% | -19.7% | -31.6% | |
| Nov 17, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 120,000 | $42.33 | $5,079,924.00 | -43.4% | -11.0% | -37.2% | |
| Sep 15, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 100,000 | $42.30 | $4,230,387.49 | -26.5% | -1.2% | -33.0% | |
| Aug 9, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 45,000 | $43.73 | $1,967,823.00 | -10.7% | -2.6% | -29.4% | |
| Jun 29, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 30,000 | $42.17 | $1,265,238.00 | -6.6% | -4.0% | -26.7% |